Exacerbations of Chronic Bronchitis

• FDA approval · 2020-04-22
  FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)

  FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.

• CLINICAL_TRIALS trial_result · 2014-09-26
  Clinical Trial Update: A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) [Phase 2]

  A Phase 2 multicenter, randomized, double-blind trial evaluated the dose optimization of HL301 (mixed extract of Rehmannia glutinosa, Schisa…

• CLINICAL_TRIALS research · 2014-06-06
  Clinical Trial Update: A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control [Phase 3]

  This is a Phase 3, multi-center, randomized, double-dummy trial assessing the safety and efficacy of Prulifloxacin film-coated tablets compa…

• FDA approval · 2012-07-25
  FDA Approved: CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved a generic clarithromycin product under an original ANDA from Rising Pharma Holdings, Inc.